By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Independent Experts Say Bay Area's OncoMed (OMED)'s Pancreatic Cancer Drug Unlikely to Succeed in Phase II Study 1/25/2016 6:07:01 AM
OncoMed Pharmaceuticals, Inc. (OMED) Achieves $72.5 Million In Milestone Payments From Celgene (CELG); Announces Year-End Cash Balance 1/5/2016 10:54:38 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At Upcoming Investor Conferences 11/13/2015 10:30:35 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Immuno-oncology Data For Combined Blockade Of DLL4, VEGF And PD1 At The Society For Immunotherapy Of Cancer Annual Meeting 11/9/2015 12:10:00 PM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data From Brontictuzumab, Vantictumab And Anti-DLL4/VEGF Bispecific Programs At The AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics 11/9/2015 12:06:45 PM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Immuno-Oncology Data For Combined Blockade Of DLL4, VEGF And PD1 At The Society For Immunotherapy Of Cancer Annual Meeting 11/9/2015 10:17:01 AM
OncoMed Pharmaceuticals, Inc. (OMED) Reports Third Quarter 2015 Financial Results 11/5/2015 11:31:37 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Preclinical Data For The Combination Of Anti-DLL4/VEGF Bispecific Plus Anti-PD1 At The Society Of Immunotherapy For Cancer Meeting 11/5/2015 10:41:29 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Report Third Quarter 2015 Financial Results On Thursday, November 5, 2015 10/29/2015 11:43:27 AM
OncoMed Pharmaceuticals, Inc. (OMED) Announces Multiple Abstracts Accepted For Presentation At The AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics 10/27/2015 10:32:07 AM
12345678910...
//-->